Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells
- 18 May 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 385 (2), 198-203
- https://doi.org/10.1016/j.bbrc.2009.05.038
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancerBMC Cancer, 2008
- PI3K/Akt‐dependent transcriptional regulation and activation of BMP‐2‐Smad signaling by NF‐κB in metastatic prostate cancer cellsThe Prostate, 2008
- NDRG2 suppresses cell proliferation through down‐regulation of AP‐1 activity in human colon carcinoma cellsInternational Journal of Cancer, 2008
- Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4Molecular Cancer Research, 2008
- Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell deathExperimental & Molecular Medicine, 2007
- SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cellsBiochemical and Biophysical Research Communications, 2007
- Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cellsBiochemical and Biophysical Research Communications, 2007
- Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cellsNature, 2006
- BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cellsOncogene, 2004
- The bone morphogenetic protein family and osteogenesisMolecular Reproduction and Development, 1992